News: Alimera Sciences Inc (ALIM.O)

ALIM.O on Consolidated Issue listed on NASDAQ Global Market

6.02USD
24 Oct 2014
Price Change (% chg)

$0.56 (+10.26%)
Prev Close
$5.46
Open
$5.46
Day's High
$6.08
Day's Low
$5.40
Volume
1,347,489
Avg. Vol
317,954
52-wk High
$8.44
52-wk Low
$1.76

Search Stocks
Select another date:

Fri, Sep 26 2014

Alimera, pSivida eye implant finally wins U.S. approval

- Alimera Sciences Inc and pSivida Corp said the U.S. Food and Drug Administration approved their vision-loss treatment Iluvien, following three rejections.

UPDATE 1-Alimera, pSivida eye implant finally wins U.S. approval

Sept 26 - Alimera Sciences Inc and pSivida Corp said the U.S. Food and Drug Administration approved their vision-loss treatment Iluvien, following three rejections.

Alimera's eye implant Iluvien wins FDA approval

Sept 26 - The Food and Drug Administration has approved Alimera Sciences Inc's and pSivida Corp's vision-loss treatment Iluvien after three rejections.

Select another date:
Search Stocks